Showing results (1-10 of 27) with videos related to
Sort By:
Pageof 3
CNS Drugs|June 21, 2007
CNS complications of breast cancer: current and emerging treatment optionsEvert C A Kaal, Charles J VechtCurrent Opinion in Oncology|January 1, 2005
The management of brain edema in brain tumorsEvert C A Kaal, Charles J VechtParazitologiia|August 1, 1980
[Removal of accompanying yeast fungi from cultures of trichomonad strains (Polymastigina)]E M Ryĭgas, Kh Ia Sardis, V A Kaal'Journal of Neuro-Oncology|October 11, 2005
Symptomatic management and imaging of brain metastasesEvert C A Kaal, Martin J B Taphoorn, Charles J VechtHormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|May 1, 1992
SMS 201-995 and thyroid function in acromegaly: acute, intermediate and long-term effectsS E Christensen, J Weeke, A Kaal, et al.Clinical Endocrinology|May 1, 1991
Effects of antibodies against octreotide in two patients with acromegalyH Orskov, S E Christensen, J Weeke, et al.The Lancet. Neurology|April 26, 2005
Therapeutic management of brain metastasisEvert C A Kaal, Charles G J H Niël, Charles J VechtOsteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|April 22, 2016
Hypercalcemia after discontinuation of long-term denosumab treatmentA S Koldkjær Sølling, T Harsløf, A Kaal, et al.European Journal of Endocrinology|January 1, 1997
Growth hormone binding protein and growth hormone availability in acromegalic patients treated with long-acting octreotide (Sandostatin-LAR)S Fisker, A Kaal, M Montini, et al.Metabolism: Clinical and Experimental|September 1, 1992
Preliminary results with Sandostatin nasal powder in acromegalic patientsA G Harris, J Weeke, S E Christensen, et al.Pageof 3